ANI PHARMACEUTICALS INC — Director's Dealing 2016

Apr 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-04-07

Reporting Person: Schrepfer Robert W (VP Bus Dev & Con Mfg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-07	Common Stock	A	4750	$0.00	Acquired	30312	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-07	Option to Purchase	$40.59	A	9500	Acquired	2026-04-06	Common Stock (9500)	Direct

Footnotes

F1: On April 7, 2016, the Board of Directors of the Issuer approved the grant of restricted stock, which vest in equal annual installments on the first, second, third and fourth anniversaries of the grant date.

F2: The closing price of the Issuer's common stock on The NASDAQ Global Market on the grant date.

F3: The options vest in an equal annual amount over a four-year period beginning on the first anniversary of the grant date.